Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2012
06/14/2012US20120148608 Monomethylvaline compounds capable of conjugation to ligands
06/14/2012US20120148606 Neutralizing Antibodies And Methods Of Use Thereof
06/14/2012US20120148604 Trp inhibitors and uses thereof
06/14/2012US20120148602 Cancer Treatment With Endothelin Receptor Antagonists
06/14/2012US20120148595 Gaba-linked anthracycline-lipid conjugates
06/14/2012US20120148594 Mimotopes of hiv and uses thereof
06/14/2012US20120148590 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
06/14/2012US20120148587 Polypeptide formulation
06/14/2012US20120148586 Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
06/14/2012US20120148584 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the threatment of early stage tumors
06/14/2012US20120148583 Cytokine antagonists for neurological and neuropsychiatric disorders
06/14/2012US20120148581 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes
06/14/2012US20120148577 Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection
06/14/2012US20120148573 Compositions and methods for the diagnosis and treatment of immune disorders
06/14/2012US20120148567 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents
06/14/2012US20120148565 Increasing lifespan by modulation of wwp-1 and ubc-18
06/14/2012US20120148564 Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
06/14/2012US20120148563 Method for Treating Premature Ejaculation with a Botulinum Neurotoxin
06/14/2012US20120148562 Methods and compositions for treating skin conditions associated with vascular hyper-reactivity
06/14/2012US20120148561 Use of runx3 and mir-532-5p as cancer markers and therapeutic targets
06/14/2012US20120148560 Neuroprotection from brain anoxia and reperfusion injury during stroke and compositions of pkg pathway activators and method of use thereof
06/14/2012US20120148559 Compositions and method for deimmunization of proteins
06/14/2012US20120148558 Delivery of Therapeutic Compounds to the Brain and Other Tissues
06/14/2012US20120148557 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders
06/14/2012US20120148556 Formulations for Lysosomal Enzymes
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148554 Therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes
06/14/2012US20120148539 Methods and Compositions for Tissue Engineering
06/14/2012US20120148534 Methods and compositions of treating a flaviviridae family viral infection
06/14/2012US20120148533 Combination therapy
06/14/2012US20120148532 Method of treating pulmonary disease with interferons
06/14/2012US20120148531 Fused heterocyclic derivatives and methods of use
06/14/2012US20120148530 Method for the treatment or prevention of virus infection using polybiguanide-based compounds
06/14/2012US20120148529 Use of Inclusion Bodies as Therapeutic Agents
06/14/2012US20120148528 Compositions and methods to induce targeted apoptosis
06/14/2012US20120148527 TNF Superfamily Fusion Proteins
06/14/2012US20120148526 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
06/14/2012US20120148521 Methods and Compositions for Controlled Release of Drugs
06/14/2012US20120148502 Carbohydrate-Mediated Tumor Targeting
06/14/2012US20120148499 Peptides and aptamers for targeting of neuron or nerves
06/14/2012US20120148498 Compositions and Methods for the Systemic Treatment of Arthritis
06/14/2012US20120148489 Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
06/14/2012US20120148488 Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
06/14/2012DE102010062600A1 Hydrophobisiertes Proteinhydrolysat Hydrophobized protein hydrolyzate
06/14/2012DE102010053748A1 Composition, useful to treat and/or prevent obesity, comprises a specified range of hydoxycarboxylic acid, protein powder, sodium bicarbonate and magnesium carbonate
06/14/2012CA2820384A1 Methods of metabolic targeting cancer cells using chemo- and immunotherapy for treating cancer
06/14/2012CA2819978A1 Immune restricted peptides with increased efficacy
06/14/2012CA2819810A1 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
06/14/2012CA2817941A1 A stable ready-to-use cetrorelix injection
06/14/2012CA2817122A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/13/2012EP2463307A1 Modified chaperonin 10
06/13/2012EP2463299A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
06/13/2012EP2463293A1 Azacyclohexapeptide or its pharmaceutical acceptable salt, preparing method and use thereof
06/13/2012EP2463285A1 Co-crystals and pharmaceutical compositions comprising the same
06/13/2012EP2463284A1 Co-crystals and pharmaceutical compositions comprising the same
06/13/2012EP2462990A1 Pharmaceutical composition comprising lacosamide and levetiracetam with synergistic anticonvulsant effect
06/13/2012EP2462952A1 Cancer gene therapy using nucleic acids encoding US28
06/13/2012EP2462948A1 Bacterial virulence factors and uses thereof
06/13/2012EP2462946A1 Method of inhibiting cathepsin activity
06/13/2012EP2462945A2 Method of inhibiting angiogenesis, tumorigenesis and cathepsin activity
06/13/2012EP2462944A2 Methods and compositions for prevention and treatment of diabetic and aged skin
06/13/2012EP2462943A1 Dipeptidyl peptidase-4 inhibitor
06/13/2012EP2462942A1 Plasma protein having antitussive effect
06/13/2012EP2462936A1 SiRNA mediated post-transriptional gene-silencing of genes involved in alopecia
06/13/2012EP2462932A1 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
06/13/2012EP2462923A2 Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
06/13/2012EP2462435A2 Identification and use of compounds for treating persistent pain
06/13/2012EP2461835A1 Compositions containing jarid1b inhibitors and methods for treating cancer
06/13/2012EP2461829A2 Novel proteins
06/13/2012EP2461823A1 A vaccine directed against porcine pleuropneumonia and a method to obtain such a vaccine
06/13/2012EP2461822A2 Polymer particles and uses thereof
06/13/2012EP2461821A1 Modified factor ix polypeptides and uses thereof
06/13/2012EP2461820A1 Orally administerable pharmaceutical preparation containing insulin
06/13/2012EP2461819A2 Methods and compositions for treating trinucleotide repeat disorders
06/13/2012EP2461818A1 Swallowable capsule and method for stimulating incretin production within the intestinal tract
06/13/2012EP2461806A2 Antiangiogenic small molecules and methods of use
06/13/2012EP2461800A2 Controlled release formulations of lipocalin muteins
06/13/2012EP2461681A1 Use of melanocortins to treat dyslipidemia
06/13/2012EP2461680A1 Nutritional supplement
06/13/2012EP2461673A2 Novel regulatory proteins and inhibitors
06/13/2012EP2399927A9 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
06/13/2012EP2243490B1 Insulin nasal powder inhalation
06/13/2012EP2124548B1 Disintegrin variants and pharmaceutical uses thereof
06/13/2012EP1984008B1 Ace n-domain crystal
06/13/2012EP1824775B1 Debriding composition from bromelain and methods of production thereof
06/13/2012EP1774976B1 Malignant tumor local infiltration inhibitor containing batroxobin
06/13/2012EP1740213B9 Liquid growth hormone formulation
06/13/2012EP1699460B1 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
06/13/2012EP1678202B1 Hcv ns3-ns4a protease resistance mutants
06/13/2012EP1494697B1 Monomeric and dimeric fluorescent protein variants and methods for making same
06/13/2012EP1480666B1 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
06/13/2012EP1459070B1 Methods for diagnosis and treatment of epithelial-derived cancers, such as colorectal cancers and kidney cancers
06/13/2012EP1449542B1 Hgf as genetic remedy for parkinson's disease
06/13/2012EP1447095B1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1379535B1 Expression vectors able to elicit improved immune response and methods of using same
06/13/2012EP1355666B1 Use of repulsive guidance molecule (RGM) and its modulators
06/13/2012EP1296705B1 Amyloid Beta oligomers for use in treatment, alleviation or prevention of Alzheimer's Disease
06/13/2012EP1235594B1 Inhibition of secretion from non-neuronal cells
06/13/2012EP1104296B1 Bioimplant formulation
1 ... 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 ... 3163